ClinConnect ClinConnect Logo
Search / Trial NCT06115083

Effects of Pelvic Floor Training in Male Chronic Pelvic Pain, Correlation Between Subjective and Objective Outcomes

Launched by REGION STOCKHOLM · Oct 30, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Chronic Pelvic Pain Syndrome Chronic Prostatitis With Chronic Pelvic Pain Syndrome Chronic Prostatitis Pelvic Floor Muscles Urodynamics Physiotherapy Bio Feedback

ClinConnect Summary

This clinical trial is studying how pelvic floor training can help men who suffer from chronic pelvic pain, a condition that can cause ongoing discomfort and other symptoms. The researchers want to find out if a program that includes special exercises and biofeedback (a method that helps you learn to control certain bodily functions) can lead to lasting improvements in symptoms. Participants will be asked to do these pelvic floor exercises every day for six months, along with some training sessions, while another group will continue with their usual treatment without any changes.

To be eligible for this study, men must be over 18 years old and live in Sweden, specifically diagnosed with chronic pelvic pain syndrome. However, those with certain medical conditions, such as cancer in the pelvic area or issues affecting nerve function, cannot participate. This trial is currently recruiting participants, and anyone who joins can expect to contribute to important research that may help others with similar pain issues in the future. After six months, those in the control group will also have the opportunity to join the training program.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Men over the age of 18, residents in Sweden, diagnosed with Chronic Primary Pelvic Pain Syndrome (CPPPS) according to the International Statistical Classification of Diseases and Related Health Problems (ICD-10) (N41.1 (chronic prostatitis), N41.9 (Inflammatory disease of prostate, unspecified), N50.8F (Chronic Pelvic Pain Syndrome in men)
  • Exclusion Criteria:
  • Cancer in the abdomen or pelvic organs (current or previous)
  • Congenital anomalies affecting the pelvic region (Bladder exstrophy, Myelomeningocele etc.)
  • Transsexual male, (i.e. at birth biologically female)
  • Diseases affecting the nerve function to the pelvic and/or lower extremities, other disease or ongoing treatment that could have an impact on the outcome of the study.
  • Incapability to participate in testing or follow training instructions due to mental incapacity, language difficulties etc.

About Region Stockholm

Region Stockholm is a leading healthcare authority committed to advancing medical research and improving patient care through innovative clinical trials. As a sponsor, Region Stockholm collaborates with hospitals, research institutions, and industry partners to facilitate the development of new therapies and treatment protocols. With a focus on quality, safety, and ethical standards, the organization aims to enhance health outcomes for the diverse population of Stockholm and beyond, leveraging cutting-edge research to translate scientific discoveries into effective healthcare solutions.

Locations

Stockholm, , Sweden

Patients applied

0 patients applied

Trial Officials

Lotta Renström Koskela, M.D

Principal Investigator

Karolinska University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported